Jay Moorin
CIK 1033508 · last filed 2017-01-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$31.46M
Companies
6
Total Filings
27
Lifetime Open-Market Net
-$55.10M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Director | 26,174 | $2.14 | $56.0K | -$70.97M | 10 | 2017-01-06 |
| AGILE THERAPEUTICS INC (AGRX) Delisted | 10%+ Owner | 5,062,363 | $1.51 | $7.64M | $15.00M | 1 | 2016-01-29 |
| NVD | 10%+ Owner | 6,267,570 | $5.02 | $31.46M | $0 | 1 | 2009-05-05 |
| AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | 10%+ Owner | 9,798,866 | — | — | $2.51M | 7 | 2008-10-24 |
| CADENCE PHARMACEUTICALS INC (CADX) Delisted | 10%+ Owner | 2,928,831 | — | — | -$1.63M | 2 | 2007-09-12 |
| Paratek Pharmaceuticals, Inc. (NOVC) Delisted | Director | 1,855,275 | — | — | $0 | 1 | 2007-01-19 |
Recent Filings · Page 2 of 3
27 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-03-26 | — | Sell (S) | −72,624 | -$2.01M | |
| 2015-03-18 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-03-12 | — | Sell (S) | −517,368 | -$12.91M | |
| 2015-03-09 | — | Sell (S) | −157,784 | -$4.02M | |
| 2015-01-20 | — | Buy (P) | — | $0 | |
| 2014-02-20 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Mixed | +4,804,118 | $5.00M | EDGAR |
| 2009-05-05 | NVD | Other (J) | — | $0 | EDGAR |
| 2008-10-24 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Buy (P) | +21,200 | $10.2K | EDGAR |
| 2008-10-15 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Buy (P) | +224,632 | $104.8K | EDGAR |
| 2008-09-17 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Buy (P) | +1,350,106 | $1.10M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.